IL-17 also stimulates epithelial stem cell proliferation after injuring the tissue with a carcinogenic agent (85) and the inhibition of IL-17 prevents colon cancer in an experimental murine model of colitis (86). Here, IL17A is linked to malignant colon neoplasm.